Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

$24.99

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Pfizer Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Mar 30, 2025 Dec 31, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020
Short-term borrowings, including current portion of long-term debt
Trade accounts payable
Dividends payable
Income taxes payable
Accrued compensation and related items
Deferred revenues
Other current liabilities
Current liabilities
Long-term debt, excluding current portion
Pension and postretirement benefit obligations
Noncurrent deferred tax liabilities
Other taxes payable
Other noncurrent liabilities
Noncurrent liabilities
Total liabilities
Preferred stock
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Accumulated other comprehensive loss
Total Pfizer Inc. shareholders’ equity
Equity attributable to noncontrolling interests
Total equity
Total liabilities and equity

Based on: 10-Q (reporting date: 2025-03-30), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-29), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-27), 10-Q (reporting date: 2020-06-28), 10-Q (reporting date: 2020-03-29).

Short-term borrowings, including current portion of long-term debt
Displayed a generally declining trend from 9.62% in March 2020 to a low of 0.35% in April 2022, followed by fluctuations with an increase peaking at 5.52% in September 2024, ultimately decreasing towards the end of the period at 2.15% in March 2025. This indicates variable reliance on short-term financing over time.
Trade accounts payable
Remained relatively stable with minor fluctuations, generally ranging between 2.18% and 3.45%. A moderate increase was observed during late 2021, peaking at 3.45% in December 2021, followed by a slight decline and stabilization around 2.5% in 2025.
Dividends payable
Values are intermittent but mostly remain around the 1.0–1.2% range when reported, showing consistency in dividend obligations as a portion of total liabilities and equity.
Income taxes payable
Showed variation over the periods. Initially low around 0.69% in March 2020, it increased with a notable peak at 2.51% in October 2021. Subsequently, it stabilized between 1.0% and 1.5% through early 2025, indicating a stable tax liability profile.
Accrued compensation and related items
Fluctuated moderately, ranging from approximately 0.9% to 1.98%, with higher values in early 2021 and late 2020. Lower values were observed in mid-2023, but a gradual increase was noted again towards late 2024 and early 2025.
Deferred revenues
Data started from December 2020 and showed initial growth, peaking at 3.17% in October 2022. Afterward, it trended downward steadily, reaching its lowest at 0.49% by March 2025, which may reflect changes in revenue recognition timing or contract structures.
Other current liabilities
Generally increased from 6.32% in March 2020 to 13.74% in December 2021, followed by a decline to around 7.3%-9.6%. Some volatility is observed but generally remaining in the moderate range.
Current liabilities
Displayed variation between 14.48% and 24.28%, peaking in mid-2022 and showing a general decline into late 2023, followed by fluctuations within a moderate range near 18% to 21% thereafter.
Long-term debt, excluding current portion
Started near 21.81% in March 2020, increased to approximately 28.4% in June 2020, then generally decreased to around 16.7% by late 2022. A sharp increase followed in 2023 to roughly 28%, remaining in the high 20%s through early 2025, indicating episodic changes in long-term borrowing levels.
Pension and postretirement benefit obligations
Exhibited a steady downward trend from 3.93% in March 2020 to around 0.94% through 2023 and onward, suggesting a steady reduction in pension liabilities as a proportion of total liabilities and equity.
Noncurrent deferred tax liabilities
Values decreased significantly from above 3% in early periods to below 1% post-2021, with minor fluctuations. This decline suggests possible changes in deferred tax positions or tax planning strategies.
Other taxes payable
Declined from approximately 7.34% in March 2020 to about 2.75% by March 2025, highlighting a persistent reduction in other tax-related liabilities relative to total capital structure.
Other noncurrent liabilities
Showed a gradual increase from about 4.1% in March 2020 to approximately 7.3% in early 2024, followed by minor decreases, reflecting growing noncurrent obligations not included in debt or pension items.
Noncurrent liabilities
Generally declined from a high of 45.32% in June 2020 to just under 30% in late 2022, then rebounded to around 39% in 2025, indicating shifting proportions of long-term obligations.
Total liabilities
Peaked at about 63.71% in June 2020, declined steadily to near 48% by early 2023, then re-increased to around 58.5% by early 2025, suggesting variable leverage with some deleveraging followed by re-leveraging.
Common stock
Held fairly constant in the 0.21% to 0.3% range, showing negligible change in composition as a percentage of total capital.
Additional paid-in capital
Started near 52.71%, gradually declined to the low 40%s during 2023, then showed moderate recovery reaching approximately 45.12% in 2025, indicating some fluctuations likely related to equity transactions.
Treasury stock
Consistently negative and decreasing in absolute value (implying a growing contra equity balance), moving from roughly -66.74% in March 2020 to around -55.28% in 2025, signifying ongoing share repurchase activities or treasury holdings.
Retained earnings
Remained positive and relatively stable, ranging mostly between 52% and 67%, with a peak around 67% in early 2023; this suggests solid accumulation of earnings over time despite fluctuations.
Accumulated other comprehensive loss
Maintained a negative balance throughout, worsening slightly from about -7.89% in early 2020 to near -4.12% by 2025, indicating relatively stable but slightly improving comprehensive loss impacts.
Total shareholders’ equity
Varied between approximately 36% and 52%, with a peak in early 2023 at 51.62%, then trending downward to about 39.3% in late 2023 before a moderate recovery to 43.43% in early 2025. This pattern reflects changes in net asset values and equity structure over time.
Total equity
Followed a similar trajectory to shareholders’ equity, maintaining around 36% to 52% of the total capital, with fluctuations consistent with those described above.
Total liabilities and equity
Constant at 100%, serving as the base for all percentage calculations.